TPD52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.114400E-01
Normal-vs-Stage2
3.249600E-01
Normal-vs-Stage3
5.360400E-01
Normal-vs-Stage4
1.680430E-01
Stage1-vs-Stage2
8.271400E-01
Stage1-vs-Stage3
7.751000E-01
Stage1-vs-Stage4
7.105400E-01
Stage2-vs-Stage3
8.556600E-01
Stage2-vs-Stage4
5.612600E-01
Stage3-vs-Stage4
6.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.523600E-01
Normal-vs-AfricanAmerican
3.943400E-01
Normal-vs-Asian
3.274200E-01
Caucasian-vs-AfricanAmerican
5.231800E-01
Caucasian-vs-Asian
5.566000E-01
AfricanAmerican-vs-Asian
7.727800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.474400E-01
Normal-vs-Female
3.190800E-01
Male-vs-Female
1.179820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.546200E-01
Normal-vs-Age(41-60Yrs)
2.584600E-01
Normal-vs-Age(61-80Yrs)
4.020400E-01
Normal-vs-Age(81-100Yrs)
3.557400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.115400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.803800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.141200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.166800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.114600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.281800E-01
Normal-vs-Daily Drinker
3.794200E-01
Normal-vs-Weekly Drinker
6.615800E-01
Normal-vs-Occasional Drinker
2.229600E-01
Normal-vs-Social Drinker
3.750800E-01
Non Drinker-vs-Daily Drinker
9.261000E-01
Non Drinker-vs-Weekly Drinker
2.667400E-01
Non Drinker-vs-Occasional Drinker
1.838380E-01
Non Drinker-vs-Social Drinker
8.721200E-01
Daily Drinker-vs-Weekly Drinker
3.423400E-01
Daily Drinker-vs-Occasional Drinker
1.643850E-01
Daily Drinker-vs-Social Drinker
9.441600E-01
Weekly Drinker-vs-Occasional Drinker
4.407700E-02
Weekly Drinker-vs-Social Drinker
3.914200E-01
Occasional Drinker-vs-Social Drinker
1.964440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.06680000000015E-05
Normal-vs-Grade 2
4.805700E-02
Normal-vs-Grade 3
3.785900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.053550E-01
Grade 1-vs-Grade 3
1.495000E-01
Grade 1-vs-Grade 4
2.06680000000015E-05
Grade 2-vs-Grade 3
6.955200E-01
Grade 2-vs-Grade 4
4.805700E-02
Grade 3-vs-Grade 4
3.785900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.774000E-01
Normal-vs-NonDiabetic
3.458600E-01
Diabetic-vs-NonDiabetic
3.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.138600E-01
Normal-vs-NoPancreatitis
3.630200E-01
Pancreatitis-vs-NoPancreatitis
1.287430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.635600E-01
Normal-vs-N1
3.174200E-01
N0-vs-N1
2.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.073210E-01
Normal-vs-TP53-NonMutant
3.818700E-03
TP53-Mutant-vs-TP53-NonMutant
6.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
